<DOC>
	<DOCNO>NCT02041871</DOCNO>
	<brief_summary>To study efficacy preoperative immunonutrition reduce postoperative morbidity liver resection cancer .</brief_summary>
	<brief_title>Interest PReOPerative Immunonutrition Liver Surgery Cancer</brief_title>
	<detailed_description>Perioperative immunonutrition develop improve immuno metabolic host response outcome postoperative period proven beneficial reduce significantly postoperative infectious complication length hospital stay patient undergo elective gastrointestinal surgery tumor . To date , effect preoperative oral immunonutrition ( ORAL IMPACT ) non cirrhotic patient undergo liver resection cancer unknown . The purpose study determine whether administration short-term preoperative oral immunonutrition reduce postoperative morbidity non-cirrhotic patient undergo liver resection malignant tumour .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Non cirrhotic patient Elective liver surgery cancer ( primary secondary malignant tumour ) Hepatectomy include least 1 segment 3 wedge resection Liver resection benign lesion Liver resection associate biliary tract surgery Liver resection associate gastrointestinal surgery Cirrhosis , define transient elastography ( FibroscanÂ® ) liver biopsy Renal failure Pregnancy nursing woman History hypersensitivity allergy arginine , omega3 fatty acid , nucleotides Inability take oral nutrition Mental condition render subject unable understand nature , endpoint consequence trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Liver Surgery</keyword>
	<keyword>Hepatectomy</keyword>
	<keyword>Immunonutrition</keyword>
	<keyword>Cancer</keyword>
	<keyword>Morbidity</keyword>
	<keyword>Postoperative complication</keyword>
</DOC>